Natural killer (NK) cell-based immunotherapy presents a promising a
Miao Deng;Rong Guo;Shuya Zang;Jingdong Rao;Mengmeng Li;Xian Tang;Chunyu Xia;Man Li;Zhirong Zhang;Qin He
ACS applied materials & interfaces
2021-4-21
As a non-invasive administration route, pulmonary peptide delivery
Likai Yang;Jing Luo;Sanjun Shi;Qiang Zhang;Xun Sun;Zhirong Zhang;Tao Gong
International Journal of Pharmaceutics
2013
Current clinical agents for autoimmunity disorders treatment often
Yu Fu;Leilei Wang;Wei Liu;Lan Yang;Lin Li;Luyao Wang;Xun Sun;Zhi rong Zhang;Qing Lin;Ling Zhang
Journal of Controlled Release
2021-9-10